Less than 1 percent of UK public research funding spent on antibiotic research in past 5 years

July 25, 2014

Less than 1% of research funding awarded by public and charitable bodies to UK researchers in 2008 was awarded for research on antibiotics, according to new research published in The Lancet Infectious Diseases.

The study, which is the first detailed assessment of public and charitable funding to UK researchers focusing on bacteriology and antibiotic research, suggests that present levels of funding for antibiotic research in the UK are inadequate, and will need to be urgently increased if the growing crisis of antibiotic resistance is to be tackled effectively by UK researchers.

According to lead author Professor Laura Piddock, of the University of Birmingham, UK, "The message that antibacterial (ie, antibiotic) drug resistance has become a world health crisis has been brought to global attention by WHO, the European Union (EU), the World Economic Forum, and, most recently, the UK Chief Medical Officer. As a world leader in biomedical research, UK research has an important part to play in tackling this crisis. However, our study clearly shows that the proportion of public and charitable funding for research into new antibiotics, understanding resistance mechanisms and ways of tackling resistance are inadequate for the size of the task."

Professor Piddock and her colleague analysed funding databases for the UK's main research funding organisations, finding that of £13,8 billion total available research funding, £269 million (1,9%) was awarded to bacteriology projects, and around a third of this (£95 million or 0,7% of total funding) was awarded for research on antibiotics. Additionally, £181 million in EU funding was awarded to antibiotic research consortia including researchers based within the UK, including two EU Innovative Medicines Initiative awards, totalling £85 million.

While this article focused exclusively on research funding for antibiotics, previous studies have shown that funding for other antimicrobials (antifungals and antivirals) is similarly low as a proportion of total funding.

As well as demonstrating that the proportion of research funding given for UK antibiotic research will need to increase, the authors suggest that publically available, subject-specific, funding databases will allow investment in priority areas to be tracked in future.

"Since 2011, most new EU has focused on public–private partnerships with industry", adds Professor Piddock. "However, an increased understanding about antibiotic resistance is needed, not least to inform strategies to both minimise and prevent antibiotic-resistant bacteria arising when new treatments become available."

In a linked Comment, Dr Michael G Head from the Farr Institute, University College London, UK, said "The private sector needs to be more transparent about how much they invest in areas related to antibiotics (generation of new therapeutics being an obvious and particularly important area), so that their data can be similarly analysed in detail. Efforts to document the investments of other countries regarding antibiotic resistance research would be beneficial and would allow funders and policymakers to chart the optimum future direction of research money. Metrics to establish the true burden of and methods also to assess the likely effect of other types of research are needed; for example, preventive research such as vaccine development will affect future burdens of bacterial infections and resistance."

Explore further: High doses of antibiotics may have the potential to promote increased cross-resistance

Related Stories

High doses of antibiotics may have the potential to promote increased cross-resistance

June 24, 2014
Antibiotic resistance has become an increasing public health concern, with MRSA infections and last lines of antibiotic drug treatments having to be increasingly deployed in hospitals and clinics.

The UK is not investing enough in research into multi-drug resistant infections, say researchers

September 12, 2013
Although emergence of antimicrobial resistance severely threatens our future ability to treat many infections, the UK infection-research spend targeting this important area is still unacceptably small, say a team of researchers ...

CDC addresses burden, threat of antibiotic resistance

January 6, 2014
(HealthDay)—The burden and threats posed by antibiotic resistance infections are discussed in a report published by the U.S. Centers for Disease Control and Prevention.

Sewage treatment contributes to antibiotic resistance

July 21, 2014
Wastewater treatment plants are unwittingly helping to spread antibiotic resistance, say scientists.

Joining forces globally against drug resistant bacteria

April 2, 2014
Antibiotics have saved millions of lives from once deadly infectious diseases. But, misuse of antibiotics and other antimicrobials in humans and animals has led to bacteria evolving resistance.

Can your pet give you an antibiotic-resistant disease?

June 11, 2014
You may think twice before letting your dog give you a big slobbery kiss following the funding of new research into how pets may transmit antibiotic resistant infections to humans.

Recommended for you

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Mind-body therapies immediately reduce unmanageable pain in hospital patients

July 25, 2017
Mindfulness training and hypnotic suggestion significantly reduced acute pain experienced by hospital patients, according to a new study published in the Journal of General Internal Medicine.

Research examines lung cell turnover as risk factor and target for treatment of influenza pneumonia

July 24, 2017
Influenza is a recurring global health threat that, according to the World Health Organization, is responsible for as many as 500,000 deaths every year, most due to influenza pneumonia, or viral pneumonia. Infection with ...

Scientists propose novel therapy to lessen risk of obesity-linked disease

July 24, 2017
With obesity related illnesses a global pandemic, researchers propose in the Journal of Clinical Investigation using a blood thinner to target molecular drivers of chronic metabolic inflammation in people eating high-fat ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.